161 related articles for article (PubMed ID: 35833862)
1. Inflammation Markers Have Important Value in Predicting Relapse in Patients with papillary thyroid carcinoma: A Long-Term Follow-Up Retrospective Study.
Huang Y; Liu Y; Mo G; Zhou T; Hou Q; Shi C; Jiang Q; Lv Y
Cancer Control; 2022; 29():10732748221115236. PubMed ID: 35833862
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of inflammatory markers LMR, PLR, MPV, FIB in intermediate-and high-risk papillary thyroid carcinoma.
Li C; Li J; Li S; Zhao Y; Liu G; Du R; Dionigi G; Liang N; Sun H
Front Endocrinol (Lausanne); 2022; 13():984157. PubMed ID: 36060974
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of a Prognostic Model Based on Lymphocyte-to-Monocyte Ratio Before Radioiodine Therapy for Recurrence of Papillary Thyroid Carcinoma.
Zhou C; Duan D; Liu S
Technol Cancer Res Treat; 2021; 20():15330338211027910. PubMed ID: 34191658
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment albumin globulin ratio has a superior prognostic value in laryngeal squamous cell carcinoma patients: a comparison study.
Zhou T; Yu ST; Chen WZ; Xie R; Yu JC
J Cancer; 2019; 10(3):594-601. PubMed ID: 30719156
[No Abstract] [Full Text] [Related]
5. Prognostic Impact of Inflammatory Markers PLR, LMR, PDW, MPV in Medullary Thyroid Carcinoma.
Li C; Zhang H; Li S; Zhang D; Li J; Dionigi G; Liang N; Sun H
Front Endocrinol (Lausanne); 2022; 13():861869. PubMed ID: 35350101
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer.
Yokota M; Katoh H; Nishimiya H; Kikuchi M; Kosaka Y; Sengoku N; Watanabe M; Yamashita K
J Surg Res; 2020 Feb; 246():535-543. PubMed ID: 31711613
[TBL] [Abstract][Full Text] [Related]
7. The potential association of peripheral inflammatory biomarkers in patients with papillary thyroid cancer before radioiodine therapy to clinical outcomes.
Cao J; He X; Li X; Sun Y; Zhang W; Li Y; Zhu X
Front Endocrinol (Lausanne); 2023; 14():1253394. PubMed ID: 38161980
[TBL] [Abstract][Full Text] [Related]
8. Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma.
Jiang K; Lei J; Chen W; Gong Y; Luo H; Li Z; Gong R; Zhu J
Medicine (Baltimore); 2016 Oct; 95(40):e5079. PubMed ID: 27749581
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index in low-risk differentiated thyroid carcinoma.
Offi C; Romano RM; Cangiano A; Candela G; Docimo G
Acta Otorhinolaryngol Ital; 2021 Feb; 41(1):31-38. PubMed ID: 33746220
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
[TBL] [Abstract][Full Text] [Related]
11. Does the Preoperative Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio Associate with Clinic-pathological Characteristics in Papillary Carcinoma of Thyroid.
Shrestha BL; Kc AK; Rajbhandari P; Dhakal A; Shrestha KS
Kathmandu Univ Med J (KUMJ); 2021; 19(74):225-229. PubMed ID: 34819441
[TBL] [Abstract][Full Text] [Related]
12. Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle- invasive bladder cancer undergoing radical cystectomy.
Lei Y; Jiao D; Yao Z; Wang L; Zhao Z
Arch Esp Urol; 2022 Apr; 75(3):287-294. PubMed ID: 35435163
[TBL] [Abstract][Full Text] [Related]
13. [Correlation analysis of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and central cervical lymph node metastasis of papillary thyroid microcarcinoma].
Song CY; Meng YL; Liu B; Yan L; Shang PZ; Jia ZF; Jiang YB; Meng FY
Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):944-948. PubMed ID: 34530577
[No Abstract] [Full Text] [Related]
14. Expression and prognostic value of ratios of platelet lymphocyte, neutrophil lymphocyte and lymphocyte monocyte in breast cancer patients.
Song D; Li X; Zhang X
Am J Transl Res; 2022; 14(5):3233-3239. PubMed ID: 35702097
[TBL] [Abstract][Full Text] [Related]
15. Cumulative Scoring Systems and Nomograms for Predicating Survival in Patients With Glioblastomas: A Study Based on Peripheral Inflammatory Markers.
Yang C; Lan T; Wang Y; Huang WH; Li SM; Li J; Li FP; Li YR; Wang ZF; Li ZQ
Front Oncol; 2022; 12():716295. PubMed ID: 35719947
[TBL] [Abstract][Full Text] [Related]
16. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
Zhang LX; Wei ZJ; Xu AM; Zang JH
Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
[TBL] [Abstract][Full Text] [Related]
17. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?
Lang BH; Ng CP; Au KB; Wong KP; Wong KK; Wan KY
World J Surg; 2014 Oct; 38(10):2605-12. PubMed ID: 24809487
[TBL] [Abstract][Full Text] [Related]
18. Systemic Immune-Inflammation Index Predicts Tumor Recurrence after Radical Resection for Colorectal Cancer.
Nakamoto S; Ohtani Y; Sakamoto I; Hosoda A; Ihara A; Naitoh T
Tohoku J Exp Med; 2023 Nov; 261(3):229-238. PubMed ID: 37673651
[TBL] [Abstract][Full Text] [Related]
19. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
